Geneva Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,405
| Closed | -$981K | – | 72 |
|
|
2024
Q4 | $981K | Sell |
11,405
-43,602
| -79% | -$3.75M | 0.4% | 45 |
|
|
2024
Q3 | $6.55M | Sell |
55,007
-5,705
| -9% | -$679K | 2.84% | 12 |
|
|
2024
Q2 | $8.67M | Sell |
60,712
-935
| -2% | -$133K | 3.57% | 7 |
|
|
2024
Q1 | $7.92M | Sell |
61,647
-210
| -0.3% | -$27K | 3.49% | 7 |
|
|
2023
Q4 | $6.4M | Buy |
61,857
+9,851
| +19% | +$1.02M | 3.54% | 9 |
|
|
2023
Q3 | $4.73M | Buy |
52,006
+1,860
| +4% | +$169K | 3.14% | 13 |
|
|
2023
Q2 | $3.91M | Buy |
50,146
+9,144
| +22% | +$714K | 2.55% | 16 |
|
|
2023
Q1 | $3.26M | Sell |
41,002
-700
| -2% | -$55.7K | 2.79% | 15 |
|
|
2022
Q4 | $2.82M | Buy |
41,702
+20,090
| +93% | +$1.36M | 2.67% | 14 |
|
|
2022
Q3 | $1.08M | Buy |
+21,612
| New | +$1.08M | 1.23% | 26 |
|